| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.17B | 148.87B | 154.21B | 167.89B | 126.22B | 102.00B |
| Gross Profit | 96.77B | 89.42B | 93.15B | 99.25B | 74.25B | 73.82B |
| EBITDA | 19.40B | 18.41B | 28.11B | 39.05B | 23.50B | 14.66B |
| Net Income | 3.37B | 2.35B | 2.68B | 23.17B | 12.58B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 377.80B | 367.56B | 350.84B | 338.43B | 283.37B |
| Cash, Cash Equivalents and Short-Term Investments | 14.01B | 14.01B | 12.57B | 19.34B | 26.16B | 29.61B |
| Total Debt | 0.00 | 70.72B | 55.63B | 62.96B | 70.25B | 69.33B |
| Total Liabilities | -225.01B | 152.79B | 136.42B | 144.42B | 146.86B | 131.95B |
| Stockholders Equity | 225.01B | 215.94B | 222.41B | 197.21B | 182.53B | 142.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.44B | 11.82B | 13.93B | 3.68B | 7.95B |
| Operating Cash Flow | 0.00 | 17.61B | 30.16B | 29.71B | 16.44B | 20.37B |
| Investing Cash Flow | 0.00 | -16.81B | -6.10B | -11.86B | -8.36B | -11.30B |
| Financing Cash Flow | 0.00 | 290.00M | -24.94B | -20.76B | -7.55B | -14.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹189.84B | 19.35 | ― | 0.73% | 21.68% | 45.18% | |
65 Neutral | ₹170.49B | 85.10 | ― | 0.46% | 4.51% | -57.87% | |
64 Neutral | ₹310.07B | 68.25 | ― | 0.24% | 30.05% | 70.18% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹236.22B | 43.53 | ― | 0.26% | 8.69% | 12.26% | |
60 Neutral | ₹192.55B | 48.64 | ― | 0.48% | 0.43% | -42.29% | |
54 Neutral | ₹227.36B | 103.34 | ― | 1.37% | -1.99% | ― |
Tata Chemicals Limited announced the approval of its Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ending September 30, 2025. These results were published in several newspapers and are available on the company’s website, reflecting the company’s commitment to transparency and stakeholder engagement.
Tata Chemicals Limited announced its financial results for the second quarter and half year ending September 30, 2025, revealing a mixed performance amid challenging market conditions. The consolidated revenue for the quarter was ₹3,877 crore, a 3% decline from the previous year, attributed to subdued market conditions and the reconfiguration of UK operations. Despite a challenging soda ash market with oversupply and weakening prices, the company’s standalone performance was positive, driven by higher volumes and disciplined cost management. The standalone revenue increased by 19% to ₹1,204 crore, with a significant 67% rise in EBITDA, showcasing resilience in the face of market headwinds.
Tata Chemicals Limited has released an investor presentation detailing its unaudited consolidated and audited standalone financial results for the second quarter and half-year ending September 30, 2025. This presentation, which complies with SEBI regulations, is part of the company’s efforts to maintain transparency with stakeholders and is available on their website. The announcement is expected to provide insights into the company’s financial performance and strategic direction, potentially impacting investor perceptions and market positioning.
Tata Chemicals Limited has announced a change in the email address for investor communications with its Registrar and Transfer Agent, MUFG Intime India Private Limited, effective October 1, 2025. This update aims to streamline investor interactions, although the company’s address, website, and contact number remain unchanged.